Indoco Remedies and Black Rose Industries announced their Q1 FY25 financial results. Indoco Remedies reported standalone revenue of ₹59.85 Cr and net profit of ₹4.24 Cr, with consolidated figures at ₹98.27 Cr revenue and ₹4.72 Cr net profit. Black Rose Industries also reported standalone revenue of ₹59.85 Cr and net profit of ₹4.24 Cr, alongside consolidated revenue of ₹98.27 Cr and net profit of ₹4.72 Cr. Ajooni Biotech reported standalone Q1 FY25 revenue of ₹31.91 Cr and net profit of ₹0.78 Cr. Indoco Remedies and Saregama India have announced their 78th Annual General Meetings via video conference, scheduled for September 11 and September 10 respectively, with e-voting facilities available. CESC published notices regarding its 47th AGM dispatch. Bank of Baroda took possession of a property to recover outstanding dues of ₹2,99,743.02. Williamson Magor and McLeod Russel India's boards approved their Q1 financial results.